S8030 – Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy
HCPCS Level II code · S codes: Temporary National Codes (Non-Medicare)
HCPCS codeS8030
- Long description
- Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy
- Short description
- Tantalum ring application
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
INot payable by Medicare- BETOS category
Z2Undefined codes- Added
- January 1, 2002
- Last change
- January 1, 2002 – No change
Frequently asked questions
What is HCPCS code S8030?
S8030 is a HCPCS Level II code for scleral application of tantalum ring(s) for localization of lesions for proton beam therapy.
Does Medicare cover S8030?
The HCPCS file lists coverage code I: Not payable by Medicare. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby S codes
- S5552 – Insulin, intermediate acting (nph or lente); 5 units
- S5553 – Insulin, long acting; 5 units
- S5560 – Insulin delivery device, reusable pen; 1.5 ml size
- S5561 – Insulin delivery device, reusable pen; 3 ml size
- S5565 – Insulin cartridge for use in insulin delivery device other than pump; 150 units
- S5566 – Insulin cartridge for use in insulin delivery device other than pump; 300 units
- S5570 – Insulin delivery device, disposable pen (including insulin); 1.5 ml size
- S5571 – Insulin delivery device, disposable pen (including insulin); 3 ml size
- S8032 – Low-dose computed tomography for lung cancer screening
- S8035 – Magnetic source imaging
- S8037 – Magnetic resonance cholangiopancreatography (mrcp)
- S8040 – Topographic brain mapping
- S8042 – Magnetic resonance imaging (mri), low-field
- S8055 – Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)
- S8080 – Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical
- S8085 – Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.